Erythromycin: Effective Broad-Spectrum Antibiotic Treatment
| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.55 | $49.25 (0%) | 🛒 Add to cart |
| 120 | $0.50 | $65.66 $60.30 (8%) | 🛒 Add to cart |
| 180 | $0.47 | $98.49 $84.42 (14%) | 🛒 Add to cart |
| 270 | $0.44 | $147.74 $118.59 (20%) | 🛒 Add to cart |
| 360 | $0.43
Best per pill | $196.98 $153.77 (22%) | 🛒 Add to cart |
Erythromycin is a macrolide antibiotic renowned for its potent antibacterial properties and wide therapeutic applications. It functions by inhibiting bacterial protein synthesis, effectively treating numerous infections caused by susceptible organisms. This medication is available in multiple formulations, including oral tablets, topical solutions, and ophthalmic preparations, ensuring versatile treatment options tailored to specific clinical needs. Trusted by healthcare professionals worldwide, erythromycin remains a cornerstone in antimicrobial therapy due to its reliability and established efficacy profile.
Features
- Belongs to the macrolide class of antibiotics
- Available in oral, topical, and ophthalmic formulations
- Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit
- Effective against Gram-positive and some Gram-negative bacteria
- Multiple salt forms, including erythromycin base, stearate, and ethylsuccinate
- Various strengths tailored for pediatric and adult dosing
Benefits
- Effectively treats a broad range of bacterial infections, including respiratory, skin, and soft tissue infections
- Provides a suitable alternative for patients allergic to penicillin
- Offers flexible administration routes to accommodate different infection types and patient preferences
- Demonstrates a well-established safety profile with decades of clinical use
- Helps prevent serious complications from bacterial infections when used appropriately
- Supports patient compliance through multiple formulation options
Common use
Erythromycin is commonly prescribed for bacterial infections such as pharyngitis, tonsillitis, respiratory tract infections, skin and soft tissue infections, and pertussis (whooping cough). It is also used for chlamydial infections in patients who cannot tolerate tetracyclines. Topical erythromycin is frequently employed in the management of acne vulgaris due to its anti-inflammatory and antibacterial effects. Ophthalmologic preparations are indicated for bacterial conjunctivitis and prevention of ophthalmia neonatorum.
Dosage and direction
Dosage varies based on the infection type, severity, patient age, and renal function. For adults, typical oral doses range from 250 mg to 500 mg every 6 hours, or 500 mg to 1 g every 12 hours for extended-release formulations. Pediatric dosing is weight-based, usually 30–50 mg/kg/day divided into 3–4 doses. Topical formulations should be applied to affected areas twice daily. Ophthalmic ointment is typically applied as a 1 cm ribbon in the conjunctival sac up to 6 times daily. Always complete the full course as prescribed, even if symptoms improve earlier.
Precautions
Patients should inform their healthcare provider of any history of liver disease, kidney impairment, or myasthenia gravis. Use with caution in patients with prolonged QT interval or those taking medications that prolong QT interval. Avoid concomitant use with ergot derivatives or CYP3A4 substrates due to increased risk of adverse effects. May cause gastrointestinal upset; taking with food can minimize this effect. Not recommended during pregnancy unless clearly needed and benefits outweigh risks.
Contraindications
Erythromycin is contraindicated in patients with known hypersensitivity to macrolide antibiotics. Contraindicated in patients taking cisapride, pimozide, or ergotamine due to potential for serious drug interactions. Should not be used in patients with pre-existing cardiac conditions associated with prolonged QT interval. Avoid use in patients with hepatic impairment or history of hepatitis associated with erythromycin use.
Possible side effect
Common side effects include nausea, vomiting, diarrhea, abdominal pain, and loss of appetite. Less frequently, patients may experience rash, itching, or dizziness. Serious side effects include hearing loss, hepatotoxicity, QT prolongation, and pseudomembranous colitis. Topical applications may cause skin dryness, peeling, or irritation. Ophthalmic preparations might cause temporary blurred vision or eye irritation. Report any severe or persistent side effects to a healthcare provider immediately.
Drug interaction
Erythromycin inhibits CYP3A4 enzyme, potentially increasing levels of numerous medications including statins, benzodiazepines, anticoagulants, and anticonvulsants. Concurrent use with other QT-prolonging agents increases cardiac risk. May reduce effectiveness of oral contraceptives; additional contraception recommended. Interacts with digoxin, theophylline, and cyclosporine, requiring dosage adjustments. Avoid concomitant administration with clindamycin or chloramphenicol due to antagonistic effects.
Missed dose
If a dose is missed, take it as soon as remembered unless it’s nearly time for the next dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure consistent antibiotic levels. For topical or ophthalmic formulations, apply the missed dose when remembered unless close to next application time.
Overdose
Symptoms of overdose may include severe nausea, vomiting, diarrhea, hearing loss, and hepatotoxicity. In case of suspected overdose, seek immediate medical attention. Treatment is supportive and may include gastric lavage if ingestion was recent. Monitor cardiac function due to potential QT prolongation. Hemodialysis is not effective for erythromycin removal.
Storage
Store at room temperature (15–30°C) in original container, protected from light and moisture. Keep away from heat and direct sunlight. Do not freeze liquid formulations. Keep all medications out of reach of children and pets. Properly discard expired or unused medication according to local guidelines.
Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any medication. The prescribing physician should determine appropriate treatment based on individual patient factors. Never share prescription medications with others.
Reviews
Clinical studies demonstrate erythromycin’s efficacy with success rates exceeding 85% for indicated infections. Healthcare professionals appreciate its versatility and reliability, particularly for penicillin-allergic patients. Some patients report gastrointestinal side effects as the most common drawback. Overall satisfaction remains high when used appropriately under medical supervision. Long-term clinical experience supports its continued use in modern antimicrobial therapy.